Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

C Hyde, B Wake, S Bryan, PM Barton, A Fry-Smith, C Davenport, F Song

Research output: Contribution to journal › Article

13 Citations (Scopus)

Original language	English
Pages (from-to)	1-89
Number of pages	89
Journal	Health Technology Assessment
Volume	6
Issue number	2
Publication status	Published - 2002

Cite this

@article{094263bceaff4854aa5ff4e832fc5106,

title = "Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment",

author = "C Hyde and B Wake and S Bryan and PM Barton and A Fry-Smith and C Davenport and F Song",

year = "2002",

language = "English",

volume = "6",

pages = "1--89",

journal = "Health Technology Assessment",

issn = "1366-5278",

publisher = "National Co-ordinating Centre for HTA",

number = "2",

}

TY - JOUR

T1 - Fludarabine as second-line therapy for B cell chronic lymphocytic leukaemia: a technology assessment

AU - Hyde, C

AU - Wake, B

AU - Bryan, S

AU - Barton, PM

AU - Fry-Smith, A

AU - Davenport, C

AU - Song, F

PY - 2002

Y1 - 2002

M3 - Article

VL - 6

SP - 1

EP - 89

JO - Health Technology Assessment

JF - Health Technology Assessment

SN - 1366-5278

IS - 2

ER -